IKK-16, IkappaB kinase inhibitor
Be the first to review this product! Submit a review
|
(3 Publications)
- FuncS
PubMed
Functional Studies - IKK-16, IkappaB kinase inhibitor (AB216471)
Inhibition of the TAK1-NFkB axis phenocopies FLT3-L deprivation.
A) Percentage of Annexin V-positive CB MLL-AF9 cells after 24 hours incubation with DMSO or AZ-TAK1 inhibitor or IKK VII in different concentrations (technical triplicate ± s.d of 3 independent experiments).
Carretta et al PLoS One. 2017 Dec 14;12(12):e0189102. doi: 10.1371/journal.pone.0189102. eCollection 2017. Fig 5. Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/
- Chemical Structure
Lab
Chemical Structure - IKK-16, IkappaB kinase inhibitor (AB216471)
2D chemical structure image of ab216471, IKK-16, IkappaB kinase inhibitor
Product details
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Cell death and differentiation 29:1211-1227 PubMed34862482
2021
Applications
Unspecified application
Species
Unspecified reactive species
Glia 69:1478-1493 PubMed33556209
2021
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 12:e0189102 PubMed29240787
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com